BRIEF published on 07/08/2026 at 15:20, 2 months 2 days ago Vanguard's Investment Position in Intertek Group plc Revealed Takeover Code Securities Disclosure Vanguard Group Investment Position Intertek Group
PRESS RELEASE published on 07/08/2026 at 15:15, 2 months 2 days ago Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc The Vanguard Group, Inc. discloses a 5.63% stake in Intertek Group plc as of 07 July 2026. Details of securities and dealings provided Securities Dealings Vanguard Group Financial Disclosure Stock Holdings Intertek Group Plc
BRIEF published on 07/07/2026 at 14:49, 2 months 3 days ago The Vanguard Group Discloses Position in Intertek Group Plc Ordinary Shares Takeover Code Vanguard Group Share Disclosure Intertek Group
PRESS RELEASE published on 07/07/2026 at 14:44, 2 months 3 days ago Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc The Vanguard Group, Inc. discloses a 5.63% interest in Intertek Group plc as of 06 July 2026 through Form 8.3. Details of securities owned provided Form 8.3 The Vanguard Group Securities Disclosure Financial Holdings Intertek Group Plc
BRIEF published on 07/03/2026 at 15:28, 2 months 7 days ago Vanguard Group's Stake in Intertek Group Plc Takeover Code Vanguard Group Shareholding Stock Transactions Intertek Group
PRESS RELEASE published on 07/03/2026 at 15:23, 2 months 7 days ago Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc The Vanguard Group, Inc. files form 8.3 for Intertek Group plc disclosing 5.63% ownership of relevant securities on 02 July 2026 The Vanguard Group, Inc. Form 8.3 Relevant Securities Ownership Disclosure Intertek Group Plc
BRIEF published on 07/02/2026 at 15:31, 2 months 8 days ago Disclosure of The Vanguard Group's Position in Intertek Group plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group Intertek Group
PRESS RELEASE published on 07/02/2026 at 15:26, 2 months 8 days ago Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc The Vanguard Group, Inc. discloses 5.63% stake in Intertek Group plc. Public filing as per Rule 8.3 of the Takeover Code. Details of ownership and positions included Securities The Vanguard Group Rule 8.3 Ownership Disclosure Intertek Group Plc
BRIEF published on 07/01/2026 at 15:12, 2 months 9 days ago Vanguard Group Discloses Significant Stake in Intertek Group Takeover Code Vanguard Group Stake Disclosure Trading Activity Intertek Group
PRESS RELEASE published on 07/01/2026 at 15:07, 2 months 9 days ago Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc The Vanguard Group, Inc. discloses a 5.63% stake in Intertek Group plc as of 30 June 2026. Purchases and sales of 1p ordinary shares are reported Sales The Vanguard Group, Inc. Stake Disclosure Purchases Intertek Group Plc
Published on 09/10/2026 at 22:25, 14 hours 35 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 21 hours 40 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 22 hours ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 11:43, 1 hour 16 minutes ago Skyborn reaches Financial Close on the Gennaker offshore wind farm project
Published on 09/11/2026 at 11:35, 1 hour 24 minutes ago EQS-Adhoc: Correction of a release from 10/09/2026, 19:35 CET/CEST - United Internet AG: Group subsidiaries 1&1 AG and IONOS Group SE launch transformation programs
Published on 09/11/2026 at 11:30, 1 hour 30 minutes ago Galimedix Therapeutics to present functional feasibility data from Phase 2 eDREAM study in geographic atrophy at 26th EURETINA Congress
Published on 09/11/2026 at 10:15, 2 hours 44 minutes ago TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
Published on 09/11/2026 at 07:00, 6 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 17 hours 30 minutes ago Availability of the 2026 Interim Financial Report
